As shown in Fig. 2B, C, miR-193b-3p inhibitors significantly promoted the expression of psoriasis-related genes and inflammatory genes, as well as the STAT3 and NF-κB pathways in the presence or absence of M5 treatment. The gene discussed is NFKB1; the disease is psoriasis.